Progression of diethylnitrosamine-induced hepatic carcinogenesis in carnitine-depleted rats

World Journal of Gastroenterology

Volumn 15, Issue 11, 2009, Pages 1373-1380

  Al Rejaie, Salim S ^a   Aleisa, Abdulaziz M ^a   Al Yahya, Abdulaziz A ^a   Bakheet, Saleh A ^a   Alsheikh, Abdulmalik ^a   Fatani, Amal G ^a   Al Shabanah, Othman A ^a   Sayed Ahmed, Mohamed M ^a  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

Carnitine deficiency; D carnitine; Diethylnitrosamine; Hepatic carcinogenesis; L carnitine

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; CARBON TETRACHLORIDE; CARNITINE; CATALASE; CORN OIL; DIETHYLNITROSAMINE; GAMMA GLUTAMYLTRANSFERASE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; MILDRONATE; NITRATE; NITRITE; SODIUM CHLORIDE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; BILIRUBIN;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BILIRUBIN BLOOD LEVEL; CANCER GROWTH; CARNITINE DEFICIENCY; CONTROLLED STUDY; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HISTOPATHOLOGY; LIVER CANCER; LIVER CARCINOGENESIS; MALE; NONHUMAN; RAT; SINGLE DRUG DOSE; SUPPLEMENTATION; ANIMAL; CHEMICALLY INDUCED DISORDER; DIET SUPPLEMENTATION; DISEASE COURSE; ENZYMOLOGY; LIPID PEROXIDATION; LIVER TUMOR; METABOLISM; PATHOPHYSIOLOGY; WISTAR RAT;

ALANINE TRANSAMINASE; ALKALINE PHOSPHATASE; ANIMALS; BILIRUBIN; CARNITINE; CATALASE; DIETARY SUPPLEMENTS; DIETHYLNITROSAMINE; DISEASE PROGRESSION; GAMMA-GLUTAMYLTRANSFERASE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; LIPID PEROXIDATION; LIVER NEOPLASMS; MALE; RATS; RATS, WISTAR; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

EID: 65649154384     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.15.1373     Document Type: Article

References (58)

1. Qian Y, Ling CQ. Preventive effect of Ganfujian granule on experimental hepatocarcinoma in rats. World J Gastroenterol 2004; 10: 755-757
2. Harris CC, Sun T. Multifactoral etiology of human liver cancer. Carcinogenesis 1984; 5: 697-701
3. Farazi1 PA, DePinho RA. Hepatocellular carcinoma pathogenesis: from genes to environment. Nat Rev Cancer 2006; 6: 674-687
4. Jemal A, Siegel R, Ward E, Murray T, Xu JQ, Thun MJ. Cancer Statistics, 2007. CA Cancer J Clin 2007; 57: 43-66
5. Brown JL. N-Nitrosamines. Occup Med 1999; 14: 839-848
6. Sullivan BP, Meyer TJ, Stershic MT, Keefer LK. Acceleration of N-nitrosation reactions by electrophiles. IARC Sci Publ 1991; 370-374
7. Reh BD, Fajen JM. Worker exposures to nitrosamines in a rubber vehicle sealing plant. Am Ind Hyg Assoc J 1996; 57: 918-923
8. Bhosale P, Motiwale L, Ingle AD, Gadre RB, Rao KVK. Protective effect of Rhodotorula glutinis NCIM3353 on the development of hepatic preneoplastic lesions. Curr Sci 2002; 83: 303-308
9. Lemoine A, Azoulay D, Jezequel-Cuer M, Debuire B. [Hepatocellular carcinoma] Pathol Biol (Paris) 1999; 47: 903-910
10. Baffis V, Shrier I, Sherker AH, Szilagyi A. Use of interferon for prevention of hepatocellular carcinoma in cirrhotic patients with hepatitis B or hepatitis C virus infection. Ann Intern Med 1999; 131: 696-701
11. Young KJ, Lee PN. Intervention studies on cancer. Eur J Cancer Prev 1999; 8: 91-103
12. Sivaramakrishnan V, Shilpa PN, Praveen Kumar VR, Niranjali Devaraj S. Attenuation of N-nitrosodiethylamine-induced hepatocellular carcinogenesis by a novel flavonol-Morin. Chem Biol Interact 2008; 171: 79-88
13. Ramakrishnan G, Raghavendran HR, Vinodhkumar R, Devaki T. Suppression of N-nitrosodiethylamine induced hepatocarcinogenesis by silymarin in rats. Chem Biol Interact 2006; 161: 104-114
14. Kweon S, Park KA, Choi H. Chemopreventive effect of garlic powder diet in diethylnitrosamine-induced rat hepatocarcinogenesis. Life Sci 2003; 73: 2515-2526
15. Yadav AS, Bhatnagar D. Chemo-preventive effect of Star anise in N-nitrosodiethylamine initiated and phenobarbital promoted hepato-carcinogenesis. Chem Biol Interact 2007; 169: 207-214
16. Singh JP, Selvendiran K, Banu SM, Padmavathi R, Sakthisekaran D. Protective role of Apigenin on the status of lipid peroxidation and antioxidant defense against hepatocarcinogenesis in Wistar albino rats. Phytomedicine 2004; 11: 309-314
17. Barbisan LF, Scolastici C, Miyamoto M, Salvadori DM, Ribeiro LR, da Eira AF, de Camargo JL. Effects of crude extracts of Agaricus blazei on DNA damage and on rat liver carcinogenesis induced by diethylnitrosamine. Genet Mol Res 2003; 2: 295-308
18. Bremer J. Carnitine - metabolism and functions. Physiol Rev 1983; 63: 1420-1480
19. Bieber LL. Carnitine. Annu Rev Biochem 1988; 57: 261-283
20. Arrigoni-Martelli E, Caso V. Carnitine protects mitochondria and removes toxic acyls from xenobiotics. Drugs Exp Clin Res 2001; 27: 27-49
21. Carter AL, Abney TO, Lapp DF. Biosynthesis and metabolism of carnitine. J Child Neurol 1995; 10 Suppl 2: S3-S7
22. Schulz H. Beta oxidation of fatty acids. Biochim Biophys Acta 1991; 1081: 109-120
23. Singh KK. Mitochondrial dysfunction is a common phenotype in aging and cancer. Ann N Y Acad Sci 2004; 1019: 260-264
24. Chang B, Ni shikawa M, Ni shiguchi S, Inoue M. L-carnitine inhibits hepatocarcinogenesis via protection of mitochondria. Int J Cancer 2005; 113: 719-729
25. Chang B, Nishikawa M, Sato E, Utsumi K, Inoue M. L-Carnitine inhibits cisplatin-induced injury of the kidney and small intestine. Arch Biochem Biophys 2002; 405: 55-64
26. Furuno T, Kanno T, Arita K, Asami M, Utsumi T, Doi Y, Inoue M, Utsumi K. Roles of long chain fatty acids and carnitine in mitochondrial membrane permeability transition. Biochem Pharmacol 2001; 62: 1037-1046
27. Hagen TM, Liu J, Lykkesfeldt J, Wehr CM, Ingersoll RT, Vinarsky V, Bartholomew JC, Ames BN. Feeding acetyl-L-carnitine and lipoic acid to old rats significantly improves metabolic function while decreasing oxidative stress. Proc Natl Acad Sci USA 2002; 99: 1870-1875
28. Luo X, Reichetzer B, Trines J, Benson LN, Lehotay DC. L-carnitine attenuates doxorubicin-induced lipid peroxidation in rats. Free Radic Biol Med 1999; 26: 1158-1165
29. Columbano A, Endoh T, Denda A, Noguchi O, Nakae D, Hasegawa K, Ledda-Columbano GM, Zedda AI, Konishi Y. Effects of cell proliferation and cell death (apoptosis and necrosis) on the early stages of rat hepatocarcinogenesis. Carcinogenesis 1996; 17: 395-400
30. el-Demerdash E, el-Denshary Eel-D, el-didi M, Al-Gharabli N, Osman AM. Probucol and liver efficiency during chemically-induced hepatocarcinogenesis. Anticancer Res 2002; 22: 977-984
31. Paulson DJ, Shug AL. Tissue specific depletion of L-carnitine in rat heart and skeletal muscle by D-carnitine. Life Sci 1981; 28: 2931-2938
32. Whitmer JT. L-carnitine treatment improves cardiac performance and restores high-energy phosphate pools in cardiomyopathic Syrian hamster. Circ Res 1987; 61: 396-408
33. Tsoko M, Beauseigneur F, Gresti J, Niot I, Demarquoy J, Boichot J, Bezard J, Rochette L, Clouet P. Enhancement of activities relative to fatty acid oxidation in the liver of rats depleted of L-carnitine by D-carnitine and a gammabutyrobetaine hydroxylase inhibitor. Biochem Pharmacol 1995; 49: 1403-1410
34. Ellman GL. Tissue sulfhydryl groups. Arch Biochem Biophys 1959; 82: 70-77
35. Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979; 95: 351-358
36. Lawrence RA, Burk RF. Glutathione peroxidase activity in selenium-deficient rat liver. Biochem Biophys Res Commun 1976; 71: 952-958
37. Higgins CP, Baehner RL, McCallister J, Boxer LA. Polymorphonuclear leukocyte species differences in the disposal of hydrogen peroxide (H2O2). Proc Soc Exp Biol Med 1978; 158: 478-481
38. Miranda KM, Espey MG, Wink DA. A rapid, simple spectrophotometric method for simultaneous detection of nitrate and nitrite. Nitric Oxide 2001; 5: 62-71
39. Alhomida AS. Study of the effects of theophylline-related changes in total, free, short- chain acyl and long-chain acyl carnitine concentrations in rat heart. Toxicology 1997; 121: 205-213
40. Longo A, Bruno G, Curti S, Mancinelli A, Miotto G. Determination of L-carnitine, acetyl-L-carnitine and propionyl -L- carni t ine in human plasma by highperformance liquid chromatography after pre-column derivatization with 1-aminoanthracene. J Chromatogr B Biomed Appl 1996; 686: 129-139
41. Sayed-Ahmed MM, Eissa MA, Kenawy SA, Mostafa N, Calvani M, Osman AM. Progression of cisplatininduced nephrotoxicity in a carnitine-depleted rat model. Chemotherapy 2004; 50: 162-170
42. Aleisa AM, Al-Majed AA, Al-Yahya AA, Al-Rejaie SS, Bakheet SA, Al-Shabanah OA, Sayed-Ahmed MM. Reversal of cisplatin-induced carnitine deficiency and energy starvation by propionyl-L-carnitine in rat kidney tissues. Clin Exp Pharmacol Physiol 2007; 34: 1252-1259
43. Al-Majed AA, Sayed-Ahmed MM, Al -Yahya AA, Aleisa AM, Al-Rejaie SS, Al-Shabanah OA. Propionyl-Lcarnitine prevents the progression of cisplatin-induced cardiomyopathy in a carnitine-depleted rat model. Pharmacol Res 2006; 53: 278-286
44. Al-Majed AA. Carnitine deficiency provokes cisplatininduced hepatotoxicity in rats. Basic Clin Pharmacol Toxicol 2007; 100: 145-150
45. Plaa GL, Hewitt WR. Detection and evaluation of chemically induced liver injury. In: Wallace Hayes A, ed. Principles and Methods of Toxicology. 2nd ed. New York: Raven Press, 1989; 399-428
46. Bulle F, Mavier P, Zafrani ES, Preaux AM, Lescs MC, Siegrist S, Dhumeaux D, Guellaen G. Mechanism of gamma-glutamyl transpeptidase release in serum during intrahepatic and extrahepatic cholestasis in the rat: a histochemical, biochemical and molecular approach. Hepatology 1990; 11: 545-550
47. Ha WS, Kim CK, Song SH, Kang CB. Study on mechanism of multistep hepatotumorigenesis in rat: development of hepatotumorigenesis. J Vet Sci 2001; 2: 53-58
48. Bansal AK, Bansal M, Soni G, Bhatnagar D. Protective role of Vitamin E pre-treatment on N-nitrosodiethylamine induced oxidative stress in rat liver. Chem Biol Interact 2005; 156: 101-111
49. Battelli D, Bellei M, Arrigoni-Martelli E, Muscatello U, Bobyleva V. Interaction of carnitine with mitochondrial cardiolipin. Biochim Biophys Acta 1992; 1117: 33-36
50. Hytiroglou P, Park YN, Krinsky G, Theise ND. Hepatic precancerous lesions and small hepatocellular carcinoma. Gastroenterol Clin North Am 2007; 36: 867-887, vii
51. Kensler TW, Trush MA. Role of oxygen radicals in tumor promotion. Environ Mutagen 1984; 6: 593-616
52. Wink DA, Cook JA, Christodoulou D, Krishna MC, Pacelli R, Kim S, DeGraff W, Gamson J, Vodovotz Y, Russo A, Mitchell JB. Nitric oxide and some nitric oxide donor compounds enhance the cytotoxicity of cisplatin. Nitric Oxide 1997; 1: 88-94
53. Watanabe K, Hess A, Bloch W, Michel O. Expression of inducible nitric oxide synthase (iNOS/NOS II) in the vestibule of guinea pigs after the application of cisplatin. Anticancer Drugs 2000; 11: 29-32
54. Arduini A. Carnitine and its acyl esters as secondary antioxidants? Am Heart J 1992; 123: 1726-1727
55. Sayed-Ahmed MM, Khattab MM, Gad MZ, Mostafa N. L-carnitine prevents the progression of atherosclerotic lesions in hypercholesterolaemic rabbits. Pharmacol Res 2001; 44: 235-242
56. Krahenbuhl S, Brass EP, Hoppel CL. Decreased carnitine biosynthesis in rats with secondary biliary cirrhosis. Hepatology 2000; 31: 1217-1223
57. Kuwajima M, Lu K, Sei M, Ono A, Hayashi M, Ishiguro K, Ozaki K, Hotta K, Okita K, Murakami T, Miyagawa J, Narama I, Nikaido H, Hayakawa J, Nakajima H, Namba M, Hanafusa T, Matsuzawa Y, Shima K. Characteristics of cardiac hypertrophy in the juvenile visceral steatosis mouse with systemic carnitine deficiency. J Mol Cell Cardiol 1998; 30: 773-781
58. Kuwajima M, Horiuchi M, Harashima H, Lu K, Hayashi M, Sei M, Ozaki K, Kudo T, Kamido H, Ono A, Saheki T, Shima K. Cardiomegaly in the juvenile visceral steatosis (JVS) mouse is reduced with acute elevation of heart shortchain acyl-carnitine level after L-carnitine injection. FEBS Lett 1999; 443: 261-266